Loading clinical trials...
Loading clinical trials...
A Phase II, Open-label Study Improving Compliance and Time of Treatment After Obtaining Complete Response Through a Tailored Schedule of Sonidegib in Locally Advanced Basal Cell Carcinomas (BCC) - the SONIBEC Trial
Conditions
Interventions
Sonidegib
Locations
1
Italy
Asst Degli Spedali Civili Di Brescia
Brescia, Italy
Start Date
January 12, 2021
Primary Completion Date
January 12, 2024
Completion Date
January 12, 2026
Last Updated
August 4, 2022
Lead Sponsor
Gruppo Oncologico del Nord-Ovest
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions